A recent study has revealed that coffee may reduce the risk of basal cell carcinoma- the most common type of skin cancer. According to the data, only caffeinated coffee seems to have an effect on the cancer risk.
Dr. Jiali Han of Brigham and Women’s Hospital explained that the data “indicates that the more caffeinated coffee you consume, the lower your risk of developing basal cell carcinoma.”
He continued, “I would not recommend increasing your coffee intake based on these data alone. However, our results add basal cell carcinoma to a list of conditions for which risk is decreased with increasing coffee consumption. This list includes conditions with serious negative health consequences such as type 2 diabetes and Parkinson’s disease.”
The cancer is known to be a slow developer, but the illness is still great and affects more than 150,000 people in the U.S. and UK each year. Han explains that this figure implies that simple dietary changes like coffee intake are likely to have a significant impact on public health.
The study, which comes from data from the Nurses’ Health Study, also analyzed the effect of decaffeinated coffee on the cancer’s appearance as well. It revealed that de-caf coffee does not decrease the risk of cancer whatsoever.
According to Dr. Han, “these results really suggest that it is the caffeine in coffee that is responsible for the decreased risk of basal cell carcinoma associated with increasing coffee consumption.
This would be consistent with published mouse data, which indicate caffeine can block skin tumor formation. However, more studies in different population cohorts and additional mechanics studies will be needed before we can say this definitively.”